247 related articles for article (PubMed ID: 22739258)
1. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
Roper J; Hung KE
Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
[TBL] [Abstract][Full Text] [Related]
2. Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.
Roper J; Martin ES; Hung KE
Curr Protoc Pharmacol; 2014 Jun; 65():14.29.1-10. PubMed ID: 24934606
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
4. Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches.
van Miltenburg MH; Jonkers J
Curr Opin Genet Dev; 2012 Feb; 22(1):21-7. PubMed ID: 22321988
[TBL] [Abstract][Full Text] [Related]
5. Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.
Belmont PJ; Budinska E; Jiang P; Sinnamon MJ; Coffee E; Roper J; Xie T; Rejto PA; Derkits S; Sansom OJ; Delorenzi M; Tejpar S; Hung KE; Martin ES
Dis Model Mech; 2014 Jun; 7(6):613-23. PubMed ID: 24742783
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of colorectal cancer and liver metastases.
Heijstek MW; Kranenburg O; Borel Rinkes IH
Dig Surg; 2005; 22(1-2):16-25. PubMed ID: 15838167
[TBL] [Abstract][Full Text] [Related]
7. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
8. Mouse models of colorectal cancer: Past, present and future perspectives.
Bürtin F; Mullins CS; Linnebacher M
World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
[TBL] [Abstract][Full Text] [Related]
9. From mice to men: GEMMs as trial patients for new NSCLC therapies.
Hayes SA; Hudson AL; Clarke SJ; Molloy MP; Howell VM
Semin Cell Dev Biol; 2014 Mar; 27():118-27. PubMed ID: 24718320
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered models have advantages over xenografts for preclinical studies.
Becher OJ; Holland EC
Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
[TBL] [Abstract][Full Text] [Related]
11. Genetically modified mouse models for biomarker discovery and preclinical drug testing.
Kucherlapati R
Clin Cancer Res; 2012 Feb; 18(3):625-30. PubMed ID: 22298895
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.
O'Rourke KP; Loizou E; Livshits G; Schatoff EM; Baslan T; Manchado E; Simon J; Romesser PB; Leach B; Han T; Pauli C; Beltran H; Rubin MA; Dow LE; Lowe SW
Nat Biotechnol; 2017 Jun; 35(6):577-582. PubMed ID: 28459450
[TBL] [Abstract][Full Text] [Related]
13. GEMMs as preclinical models for testing pancreatic cancer therapies.
Gopinathan A; Morton JP; Jodrell DI; Sansom OJ
Dis Model Mech; 2015 Oct; 8(10):1185-200. PubMed ID: 26438692
[TBL] [Abstract][Full Text] [Related]
14. Drug efficacy testing in mice.
Kim WY; Sharpless NE
Curr Top Microbiol Immunol; 2012; 355():19-38. PubMed ID: 21823029
[TBL] [Abstract][Full Text] [Related]
15. Mouse models in squamous cell lung cancer: impact for drug discovery.
Singh AP; Adrianzen Herrera D; Zhang Y; Perez-Soler R; Cheng H
Expert Opin Drug Discov; 2018 Apr; 13(4):347-358. PubMed ID: 29394493
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered mouse models in oncology research and cancer medicine.
Kersten K; de Visser KE; van Miltenburg MH; Jonkers J
EMBO Mol Med; 2017 Feb; 9(2):137-153. PubMed ID: 28028012
[TBL] [Abstract][Full Text] [Related]
17. Experimental Murine Models for Colorectal Cancer Research.
Neto Í; Rocha J; Gaspar MM; Reis CP
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174036
[TBL] [Abstract][Full Text] [Related]
18. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
Singh M; Johnson L
Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
[TBL] [Abstract][Full Text] [Related]
19. One mouse, one patient paradigm: New avatars of personalized cancer therapy.
Malaney P; Nicosia SV; Davé V
Cancer Lett; 2014 Mar; 344(1):1-12. PubMed ID: 24157811
[TBL] [Abstract][Full Text] [Related]
20. Novel drug discovery opportunities for colorectal cancer.
Curtin JC
Expert Opin Drug Discov; 2013 Sep; 8(9):1153-64. PubMed ID: 23768167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
